Data as of Apr 17
| -0.08 / -0.07%|
The 23 analysts offering 12-month price forecasts for Amgen Inc have a median target of 130.00, with a high estimate of 155.00 and a low estimate of 115.00. The median estimate represents a +12.59% increase from the last price of 115.46.
The current consensus among 28 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.